Detection with AI
Bob Wang, Founder & CEO
Releases White Paper on Artificial Intelligence Technology
and its potential impact on Breast Cancer Screening and a
clear path to saving many more lives.
"In reviewing an ABUS screening exam, I can initially examine the entire case in a single glance with QVCAD. From my early experience with QVCAD, I find ultrasound CAD much more critical for screening than mammography CAD."
Ralph Smathers - M.D.
QView Medical, Inc. is a Silicon Valley based private company. The QView team has been the leader in CAD and ABUS development. For over 20 years, members of the team have been involved in obtaining four PMA approvals: R2 mammography CAD, R2 lung CT CAD, U-Systems somo.v ABUS and QView QVCAD.